FDA committee sets stage for Epizyme's first product approval
December 18, 2019 at 12:50 PM EST
After more than a decade of ups and downs in the drug development process, Cambridge biotech Epizyme is poised to start 2020 with good news after an FDA advisory committee voiced support for its cancer drug.
